Welcome to
the Newsroom

Filter by language : NL / DE / EN / FR / ES / IT / AR
BBC
Bloomberg
Daily Mail
Forbes
TC
The Boston Globe
The Guardian
The wall street journal
November 5, 2014

A balloon for obesity: an option between medication and surgery?

LA TIMES – For many struggling with obesity, taking one of the newly approved prescription medications for weight loss (marketed as Qsymia, Belviq and Contrave) feels like climbing a mountain with a walking cane — it’s a little help, but not enough. And bariatric surgery — a permanent replumbing of the intestinal tract that is expensive and carries the risks of major surgery — feels like a bit too much help.

July 30, 2012

Expanding the Bounds of Weight Loss: Interview with Allurion Technologies Co-Founder, Shantanu Gaur

MEDGADGET – Over one-third of U.S. adults are obese, increasing their risk of certain conditions including heart disease, stroke, diabetes, and certain cancers. While bariatric procedures are indicated for refractory obesity with certain BMI criteria, those overweight individuals who do not quality are often at a loss for therapeutic solutions. The market for noninvasive innovations for these patients is emerging but is yet to have a consistently effective solution.

April 23, 2012

Weight Loss In A Pill: Will It Work?

RADIO BOSTON – With 50 percent of adult Bostonians overweight or obese, Boston Mayor Thomas Menino put forth a challenge in his State of the City address this year.